Walleye Trading LLC Gossamer Bio, Inc. Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.96 - $2.92 $114,587 - $348,537	119,362 New	119,362 $150,000
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $14,975 - $30,905	-2,077 Reduced 53.24%	1,824 $22,000
Q2 2022 Aug 08, 2022	BUY	$5.97 - $9.97 $23,288 - $38,892	3,901 New	3,901 $33,000
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $61,460 - $90,952	-7,282 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $73,693 - $102,457	7,282 New	7,282 $82,000
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $90,184 - $109,911	-11,273 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $97,285 - $123,326	11,273 New	11,273 $104,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.